Posted on September 28, 2021 by Hokkaido NewsShionogi : Notice Regarding the Initiation of a Phase 2/3 Clinical Trial for a COVID-19 Therapeutic Agent in Japan – marketscreener.com Shionogi : Notice Regarding the Initiation of a Phase 2/3 Clinical Trial for a COVID-19 Therapeutic Agent in Japan marketscreener.com
